Subject Areas :
1 - استادیار، دانشگاه ازاد اسلامی، واحد زنجان، مرکز تحقیقات بیولوژی، زنجان، ایران
Keywords:
Abstract :
. Aimbire, F., Penna, S.C., Rodrigues, M., Rodrigues, K.C., Lopes – Martins, R. AB., Sertie, JAA. (2007). Effects of hydro alcoholic extract of Zingiber officinalis rhizomes on LPS induced rat airway hyper reactivity and lung inflammation. Prostaglandins, Leukotrienes and Essential Fatty Acids, 77; 129 – 138.
2.Alberti, K., Aschner, P., Assal, JP., Bennett, P., Groop, L. (2008). Dyslipidaemia in diabetic rats. J Ethnopharmacol Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 31(1); S55-60.
3.Ali, BH., Blunden, G., Tanira, MO., Nemmar, A. (2008). Some phytochemical, pharmacological and toxicological properties of ginger. A review of recent research. Food and chemical Toxicology, 46(2); 409-20.
4.Aryaeian, N., Arablou, T., Valizadeh, M., Sharifi, F., Fatemeh Hosseini, A., Djalali ,M. (2014). .The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. International Journal of Nutrition and Food sciences, 65(4); 515-520.
5.Barzkar, Z. (2015). An applied research in properties and clinical application of bone marrow messnchymal stem cells. Jound of Fasa University of Medical Sciences, 5(2); 306-322.
6.Bianco, P., Robey, P.G., Simmons, P.J. (2008). Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell, 2; 313-319.
7.Charlier, C., Michaux, C., Dual, A. (2005). Inhibition of cyclooxygenase-2 effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascular Pharmacology, 43; 234–241.
8.Chung, SW., Kim, MK., Chung, JH., Kim, DH., Choi, JS., Anton, S. (2009). Peroxisome pro liferator activated receptor activation by a short-term feeding of zingerone in aged rats. Journal of medicinal food, 12(2); 345-50.
9.Dickenson, AH. (1994). Neuro physiology of opioid poorly responsive pain. Cancer Surv, 21; 5-16.
10.Eini, L. (2014). Expression of indoleamine 2 3-dioxygenase in endometrial mesenchymal stem cells treated with gamima interferon. Iranian Journal of Diabetes and Metabolism,13( 2); 153-162.
11.Ghasemzadeh, A., Jaafar, HZ., Rahmat, A. (2010). Identification and concentration of some flavonoid components in malaysian young ginger(Zingiber officinale ) varieties by a high performance liquid chromatography method. Molecules, 15; 6231-6243
12.Grzanna, R., Lindmark, L., Frondoza, CG. (2005). Ginger-an herbal medicinal product with broad anti-inflammatory actions. J Med Food, 8(2); 125-32.
13.Grzanna, R., Phan, P., Polotsky, A., Lindmark, L., Frondoza, CG. (2004). Ginger extract inhibits β-amyloid peptide-induced cytokine and chemokine expression in cultured thp-1 monocytes. J Altern Complement Med, 10(6); 1009-1013.
14.Guahk, GH., Ha, SK., Jung, HS., Kang, C., Kim, CH., Kim, YB. (2010). Zingiber officinale protects HaCaT cells and C57BL/6 mice from ultraviolet B-induced inflammation. Journal of medicinal food, 13(3); 673-80.
15.Habib, SHM., Makpol, S., Hamid, NAA., Das, S., Ngah, WZW., YusofI, YAM. (2008). Ginger extract(Zingiber Officinale ) has anti-cancer and anti-inflammatory effects on ethionine- induced hepatoma rats. CLINICS, 63(6); 807-813.
16.Hajar Tavakoli, H., Aryaeian, N. (2016). A review of the effect of Ginger in inflammation. Rahavard salamat journal, 2(1); 52-64.
17.Huang, Q., Iwamoto, M., Aoki, S., Tanaka, N., Tajima, K., Yamahara, J. (1991). Anti-5 hydroxy tryptamine 3 effect of galanolactone, diterpenoid isolated from ginger. Chemical & Pharmaceutical Bulletin, 39(2); 397-399
18.Kim, MK., Chung, SW., Kim, DH., Kim, JM., Lee, EK., Kim, JY. (2010). Modulation of age-related NF-κB activation by dietary zingerone via MAPK pathway. Experimental gerontology, 45(6); 419-426.
19.Lantz, RC., Chen, GJ., Sarihan, M., Sólyom, AM., Jolad, SD., Timmermann, BN. (2007). The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine, 14; 123-128.
20.Leach, MJ., Kumar, S. (2008). The clinical effectiveness of ginger(zingiber officinale) in adults with osteoarthritis. Int J Evid Based Healthc, 6(3); 11-20.
21.Lee, HY., Park, SH., Lee, M., Kim, HJ., Ryu, SY., Kim, ND. (2012). 1 Dehydro [10] gingerdione from ginger inhibits IKKβ activity for NF κB activation and suppresses NF κB regulated expression of inflammatory genes. British journal of pharmacology, 167(1); 128-140.
22.Levy, A., Simon, O. (2009). Six-shogaol inhibits production of tumour necrosis factor alpha, interleukin-1 beta and nitric oxide from lipo poly saccharide -stimulated macrophages. West Indian Med J, 58(4); 295-300.
23.Li, XH., McGrath, KCY., Nammi, S., Heather, AK., Roufogalis, BD. (2012). Attenuation of liver pro inflammatory responses by Zingiber officinale via inhibition of NF kappa B activation in high fat diet fed rats. Basic & Clinical Pharmacology & Toxicology, 110(3); 238-244.
24.Mahluji, S., Attari, VE., Mobasseri, M., Payahoo, L., Ostadrahimi, A., Golzari, SE. (2013). Effects of ginger(Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. Int J Food Sci Nutr, 64(6); 682-686.
25.Mahluji, S., Ostadrahimi, A., Mobasseri, M., Attari, VE., Payahoo, L. (2013). Anti-inflammatory effects of Zingiber officinale in type 2 diabetic patients. Advanced Pharmaceutical Bulletin, 3(2); 273-276.
26.Mu, J., Zhuang, X., Wang, Q., Jiang, H., Deng, ZB., Wang, B. (2014). Interspecies communication between plant and mouse gut host cells through edible plant derived exosome‐like nanoparticles. Molecular Nutrition & Food Research, 58(7); 1561-73.
27.Muller, W., Fiebich, BL., Stratz, T. (2006). New treatment options using 5-HT3 receptor antagonists in rheumatic diseases. Current Topics in Medicinal Chemistry, 6(18); 2035-42.
28.Navarro, JF., Mora, C. (2006). Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. Scientific World Journal, 6; 908-917.
29.Panigrahi, R. (2014). Association of TNF-α promoter polymorphism with HBV associated disease outcome among HBV infected patients from orissa,southern part of east india . Journal of Clinical and Experimental Hepatology , 4 (3); 202-208.
30.Prasanthi, K., Chagani, S., Gundala, SR., Rida, PC., Asif, G., Sharma, V. (2012). Benefits of whole ginger extract in prostate cancer. British Journal of Nutrition, 107; 473–484.
31.Raji, Y., Udoh, US., Oluwadara, OO., Akinsomisoye, OS., Awobajo, O., Adeshoga, K. (2002). Anti-inflammatory and analgesic properties of the rhizome extract of Zingiber officinale. African Journal of Biomedical Research, 5; 121-124.
32.Rang, HP., Dale, MM., Ritter, JM.(1999). Text book of pharmacology.3th ed. New York: Churchill Livingston, 148-633.
33.Rodrigues, FA., Prata, MM., Oliveira, IC., Alves, NT., Freitas, RE., Monteiro, HS. (2014). Gingerol fraction from Zingiber officinale protects against gentamicin-induced nephrotoxicity. Antimicrobial agents and chemotherapy, 58(4); 1872-8.
34.Sabina, EP., Rasool, M., Mathew, L., EzilRani, P., Indu, H. (2010). 6-Shogaol inhibits monosodium urate crystal-induced inflammation–An in vivo and in vitro study. Food and Chemical Toxicology, 48(1); 229-35.
35.Shim, S., Kim, S., Choi, D-S., Kwon, Y-B., Kwon, J. (2011). Anti-inflammatory effects of [6]-shogaol: potential roles of HDAC inhibition and HSP70 induction. Food and Chemical Toxicology, 49(11); 2734-40.
36.Shimoda, H., Shan, S-J., Tanaka, J., Seki, A., Seo, J-W., Kasajima, N. (2010). Anti-inflammatory properties of red ginger extract and suppression of nitric oxide production by its constituents. Journal of Medicinal Food, 13(1); 156-62.
37.Singh, A., Duggal, S., Singh, J., Katekhaye, S. (2010). Experimental advances in pharmacology of gingerol and analogues. Pharmacie Globale(IJCP), 2(4);1-5.
38.Toker, G., Kupeli, E., Memisoglu, M., Yesilada, E. (2004). Flavonoids with anti nociceptive and anti inflammatory activities from the leaves of Tilia argentea(Silver linden). J Ethnopharmacol, 95; 393-7.
